Table 1.
Relationship between clinicopathological features and LAG‐3 expression in patients with NSCLC (cases)
| Clinicopathological features | LAG‐3 expression | χ 2 | P | |
|---|---|---|---|---|
| Negative | Positive | |||
| Gender | ||||
| Female | 10 | 14 | 0.193 | .660 |
| Male | 10 | 18 | ||
| Pathological type | ||||
| Squamous cell carcinoma | 4 | 11 | 1.239 | .270 |
| Adenocarcinoma | 16 | 21 | ||
| T staging | ||||
| T1 | 14 | 18 | 0.983 | .320 |
| T2 ~ T4 | 6 | 14 | ||
| N staging | ||||
| N0 | 16 | 20 | 1.769 | .180 |
| N1 ~ N2 | 4 | 12 | ||
| TNM staging | ||||
| I ~ II | 19 | 21 | 5.983 | .010 |
| III | 1 | 11 | ||
| Differentiation | ||||
| High and medium differentiation | 13 | 16 | 1.123 | .290 |
| Low differentiation | 7 | 16 | ||